As community cancer care providers who experience first-hand the challenges of providing quality cancer care, ACCC members are the best positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology.
ACCC provides members with the information and resources needed to effectively advocate on the issues that are important to them. Together, we can positively influence the future of community oncology.
The Centers for Medicare & Medicaid Services (CMS) has announced a new, voluntary alternative payment model, the Enhancing Oncology Model (EOM), that will allow ACCC programs to improve care coordination and health outcomes for patients, as well as deliver high-quality and affordable cancer care to the communities they serve.
Read ACCC's history with the Cancer Moonshot initiative and how we plan to continue to support the White House through resources and tools on cancer prevention for underserved and marginalized patient populations.
The ACCC Alternative Payment Model Coalition addresses concerns about lack of preparedness to perform under Alternative Payment Models, patient and provider access to the latest treatments, infrastructure, and long-term sustainability.
The Oncology State Societies at ACCC Advocacy Engagement Pilot will establish a policy communication and learning infrastructure in nine states—Colorado, Louisiana, Missouri, New Mexico, New York, South Carolina, Texas, West Virginia, and Wisconsin—to address pressing policy issues that impact patient care and provider access. This work will focus on legislative efforts, standards of care, and health equity.
The Association of Community Cancer Centers and its Chapter Members from the Oncology State Societies at ACCC have developed resources for cancer care professionals to learn about the practice of white bagging, its deleterious effects on patient care, and how to take action against it.
On November 1, the Centers for Medicare and Medicaid Services (CMS) released the CY 2023 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) Final Rules, finalizing the agency's new reimbursement policies taking effect January 1, 2023. ACCC will host a virtual in-depth review of these final rules and their anticipated impact on oncology programs and practices as part of our 2022 Oncology Reimbursement Meetings. Register for the upcoming webinar on December 13 and view the final rules and their corresponding CMS fact sheets below:
CY 2023 Medicare Payment Resource
This member-exclusive resource provides a high-level summary of Medicare coding and reimbursement policies finalized by the Centers for Medicare and Medicaid Services (CMS) in its calendar year (CY) 2023 rulemaking cycle. Highlights include Medicare policy changes included in the CY 2023 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules, including updates to the Medicare Quality Payment Program (QPP).
Download Resource (Member Login Required)
On-Demand Webinar: The 2023 Medicare PFS and OPPS Proposed Rules: What You Need to Know
Learn about the key proposals in the CY 2023 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules and how these proposed changes to Medicare payment will impact oncology practices, freestanding cancer centers, and hospital-based cancer programs in 2023. There will be an opportunity for live Q&A.
On July 7, CMS issued the (CY) 2023 Physician Fee Schedule (PFS) proposed rule, which would significantly expand access to behavioral health services, Accountable Care Organizations (ACOs), cancer screening, and dental care—particularly in rural and underserved areas.
Read the Letter Fact Sheet
On July 15, CMS issues the (CY) 2023 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. In addition to proposing payment rates, this year’s rule includes proposals that align with several key goals of the Administration, including advancing health equity in rural areas, promoting competition in the health care system, and promoting safe, effective, and patient-centered care. The proposed rule would further the agency’s commitment to strengthening Medicare and use the lessons learned from the COVID-19 PHE to inform the approach to quality measurement.
Read the Letter Federal Register Download
ACCC believes that to improve the current treatment options available for patients at the lowest cost without decreasing access to care, the following four principles should be taken into consideration.
Any proposed changes in reimbursement for drugs, diagnostics, and biomarker testing should decrease health inequities and not negatively impact the ability of cancer programs and practices to provide necessary supportive care services for potentially disadvantaged patients.
Read the Principles
ACCC was invited to share the association’s key priorities for
impacting cancer care in the US. ACCC president Olalekan Ajayi, PharmD,
MBA, and chief operating officer at Highlands Oncology Group, PA,
discusses the meeting and these initiatives.
"Many caregivers have it together, they’re on top of everything.
They are organized, they are experts at this, but they are falling apart
inside. You aren’t going to know if you don’t ask."
Listen to ACCC's Matt Devino and President of the Empire State Hematology & Oncology Society, Rahul Seth, DO, discuss why every voice is critical in grassroots advocacy efforts on both the federal and state level, and how cancer professionals who moonlight as patient advocates can help improve access to care and reduce financial toxicity for people living with cancer.
Learn how state oncology societies have the power to mobilize larger groups of providers across the state to make their voices heard on behalf of their patients—and how you can get involved.
Biomarker testing is crucial to precision medicine, but barriers still exist. Learn from two healthcare advocates about recent policy changes designed to ensure better access to biomarker testing.
Hear from Colleen Campbell, PhD, MS, LGC, as she explains policy changes that can help patients access genetic counseling services, while also benefiting those who provide these services.
We'll discuss the telehealth regulatory and policy changes enacted during the COVID-19 pandemic, what may change in 2021, and what’s likely to remain the same regarding the reimbursement of remote care.
Cancer organizations express mixed reactions to Enhancing Oncology Model
Healio, Aug 5, 2022
Oncology Leaders Express Mixed Feelings on New CMS Enhancing Oncology Model
ObR Oncology, Jul 6, 2022
Alternate models may address ‘need to better tailor survivorship care’
Healio, June 29, 2021
ACCC Position on the Cancer Moonshot Relaunch
ACCC, Mar 2, 2022
Association of Community Cancer Centers Supports Biden’s Moonshot Plans,Offers Resources and Tools to White House Effort
ACCC, Feb 15, 2022
Association of Community Cancer Centers' Resources Support Cancer Moonshot Recommendations
ACCC, Sep 13, 2016